Pacific Shuanglin Bio-pharmacy Co., LTD (SHE: 000403)

Pacific Shuanglin Bio-pharmacy Co., LTD Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Jan 1, 2020
Cash & Equivalents	850.35	1,429	1,001	885.67	102.83	110.94
Trading Asset Securities	853.3	423.34	422.44	234.21	-	-
Cash & Short-Term Investments	1,704	1,853	1,423	1,120	102.83	110.94
Cash Growth	15.20%	30.17%	27.09%	989.09%	-7.32%	-28.32%
Accounts Receivable	533.71	619.51	891.08	581.12	314.17	241.75
Other Receivables	13.59	15.6	49.71	12.83	5.75	16.33
Receivables	547.3	635.11	940.79	593.95	319.93	258.08
Inventory	1,140	909.37	623.69	738.97	441.76	404.65
Prepaid Expenses	5.44	0.3	0.14	0	1.76	0.03
Other Current Assets	23.64	28.6	59.12	16.53	6.44	5.22
Total Current Assets	3,420	3,426	3,047	2,469	872.71	778.93
Property, Plant & Equipment	1,764	1,554	1,297	1,103	410.91	388.09
Goodwill	2,615	2,615	2,615	2,615	-	-
Other Intangible Assets	208.91	212.59	192.52	200.05	65.46	54.22
Long-Term Deferred Tax Assets	39.86	49.04	49.09	27.35	11.75	10.68
Long-Term Deferred Charges	88.37	79.47	89.7	67.42	36.04	37.06
Other Long-Term Assets	701.52	694.87	692.81	605.82	282.85	2.67
Total Assets	8,837	8,630	7,982	7,088	1,680	1,272
Accounts Payable	227.3	154.35	158.37	158.7	38.32	31.77
Accrued Expenses	299.03	373.56	373.49	239.21	171.81	259.6
Short-Term Debt	249.16	250.57	275.1	113.52	332.41	110
Current Portion of Long-Term Debt	33.98	21.22	8.63	-	-	-
Current Portion of Leases	5.95	6.67	7.14	7.05	5.28	-
Current Income Taxes Payable	20.16	39.72	43.08	24.22	18.31	8.9
Current Unearned Revenue	27.15	10.76	25.91	11.54	5.2	7.26
Other Current Liabilities	57.44	65.34	67.58	88.04	74.19	22.53
Total Current Liabilities	920.17	922.19	959.31	642.29	645.51	440.06
Long-Term Debt	222.55	196.08	52.89	-	20.02	-
Long-Term Leases	20.33	21.48	29.59	20.89	22.33	-
Long-Term Unearned Revenue	34.22	35.6	40.08	49.24	15.95	20.02
Long-Term Deferred Tax Liabilities	21.36	24.26	30.33	36.52	-	-
Other Long-Term Liabilities	9	9	9	11.14	9	9.96
Total Liabilities	1,228	1,209	1,121	760.07	712.82	470.04
Common Stock	733.04	733	732.39	732.92	492.43	272.58
Additional Paid-In Capital	4,796	4,793	4,779	4,779	52.56	116.44
Retained Earnings	2,127	1,946	1,392	846.23	455.3	411.21
Treasury Stock	-40.11	-43.17	-36.22	-32	-34.98	-
Comprensive Income & Other	0.05	0.05	0.04	-0	-	-
Total Common Equity	7,616	7,429	6,868	6,326	965.32	800.22
Minority Interest	-6.92	-6.79	-6.4	2.07	1.59	1.38
Shareholders' Equity	7,609	7,422	6,861	6,328	966.91	801.6
Total Liabilities & Equity	8,837	8,630	7,982	7,088	1,680	1,272
Total Debt	531.96	496.02	373.36	141.46	380.04	110
Net Cash (Debt)	1,172	1,357	1,050	978.42	-277.21	0.94
Net Cash Growth	16.24%	29.22%	7.30%	-	-	-
Net Cash Per Share	1.61	1.86	1.44	1.38	-0.57	0.00
Filing Date Shares Outstanding	731.04	730.82	732.39	732.92	732.04	489.22
Total Common Shares Outstanding	731.04	731.03	732.39	732.92	492.43	489.22
Working Capital	2,499	2,504	2,088	1,827	227.2	338.87
Book Value Per Share	10.42	10.16	9.38	8.63	1.96	1.64
Tangible Book Value	4,792	4,601	4,060	3,511	899.86	746
Tangible Book Value Per Share	6.56	6.29	5.54	4.79	1.83	1.52
Buildings	965.29	833.6	701.14	583.25	261.01	265.54
Machinery	992.32	961.1	920.37	729.45	324.38	358.4
Construction In Progress	670.46	582.7	385.73	334.38	32.73	8.47

Source: S&P Capital IQ. Standard template. Financial Sources.